| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.97B | 25.90B | 23.21B | 16.77B | 16.21B | 13.52B |
| Gross Profit | 14.86B | 14.84B | 13.83B | 9.98B | 9.74B | 7.92B |
| EBITDA | 7.10B | 6.52B | 5.95B | 4.02B | 3.09B | 2.76B |
| Net Income | 3.57B | 3.51B | 3.07B | 2.14B | 2.06B | 1.71B |
Balance Sheet | ||||||
| Total Assets | 28.33B | 27.40B | 25.77B | 20.94B | 21.28B | 18.96B |
| Cash, Cash Equivalents and Short-Term Investments | 9.12B | 11.61B | 12.29B | 9.68B | 9.70B | 8.40B |
| Total Debt | 7.55B | 1.86B | 3.22B | 3.16B | 3.43B | 2.91B |
| Total Liabilities | 12.18B | 10.37B | 11.95B | 8.34B | 9.06B | 7.71B |
| Stockholders Equity | 16.02B | 16.92B | 13.74B | 12.55B | 12.19B | 11.07B |
Cash Flow | ||||||
| Free Cash Flow | 5.01B | 2.65B | 6.78B | 2.54B | 2.09B | 2.70B |
| Operating Cash Flow | 6.49B | 3.98B | 7.34B | 3.05B | 2.67B | 3.13B |
| Investing Cash Flow | -2.01B | -3.10B | -2.43B | 616.56M | -685.84M | -3.86B |
| Financing Cash Flow | -3.43B | -2.94B | -2.38B | -2.49B | -1.23B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$47.65B | 10.31 | 21.66% | 6.15% | 5.51% | 3.90% | |
78 Outperform | HK$83.80B | 6.02 | 17.82% | 4.31% | 15.93% | 20.70% | |
76 Outperform | HK$19.23B | 4.32 | 14.00% | 5.87% | 14.76% | 23.04% | |
75 Outperform | HK$9.71B | 5.76 | 7.16% | ― | -6.79% | 66.07% | |
69 Neutral | HK$4.31B | 4.22 | 10.39% | 8.21% | 3.23% | -21.82% | |
63 Neutral | HK$1.85B | 2.63 | 12.81% | 7.98% | 13.52% | 4.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |